ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +16.7% ·
flujo de acciones -4.4% ·
nuevas posiciones netas +14.3%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | -1 | 146.21M | $1.22B | +9 | −10 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | — |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | — | — |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | — |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | — | −2 |
| Q2 2024 | 13 | — | 23.97M | $268.00M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 14.87M | — | $255.03M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 5.43M | +0.9% | $93.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 5.43M | +0.9% | $93.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 3.77M | +2.8% | $64.65M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 3.07M | -41.8% | $52.59M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 3.07M | -41.8% | $52.59M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 2.76M | +57.9% | $47.38M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 2.55M | -29.0% | $43.71M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 2.10M | 0.0% | $36.03M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 2.10M | 0.0% | $36.03M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.16M | +3.8% | $19.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 530.17K | -10.0% | $9.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 530.17K | -10.0% | $9.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 530.17K | -10.0% | $9.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 212.33K | +91.3% | $3.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 166.69K | +1.3% | $2.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 158.43K | Nuevo | $2.72M | 0.0% | New | 1 | SEC ↗ |
| 18 | Norges Bank ✦ (pasivo) | 119.34K | Nuevo | $2.05M | 0.0% | New | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 105.46K | -11.6% | $1.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 105.46K | -11.6% | $1.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 105.46K | -11.6% | $1.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 105.46K | -11.6% | $1.81M | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Citadel Advisors | $2.72M | 0.0% |
| Norges Bank | $2.05M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 355 tenedores, 211.31M acciones, $1.84B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.